induced by cuprizone or experimental autoimmune encephalomyelitis (Garcia et al., 2013; Lampron et al., 2015) . Microglia express Cx3cr1, and these prior studies focused on defective microglia as the underlying cause of the remyelination phenotype. However, the observations of Voronova et al. (2017) suggest that the biologically relevant target of Cx3cr1 ablation in these MS models may be the oligodendrocyte precursors or progenitors.
On another disease front, oligodendrocyte progenitors are an attractive ''cellof-origin'' candidate for malignant glioma, and neuron-derived factors are an emerging area of focus for these tumors. One recent study highlights a link between neuronal activity and glioma growth through secretion of neuroligin-3 (Venkatesh et al., 2015) . However, the work of Voronova et al. (2017) suggests that neuron-derived fractalkine might work in opposition to glioma growth. The Olig2 transcription factor-essential to formation of oligodendrocyte progenitors-is likewise essential for maintaining ''stemness'' and tumorigenic potential of patient-derived glioma cell lines (Suvà et al., 2014) . Olig2 also happens to associate with the Cx3cr1 gene in postnatal oligodendrocyte progenitors (Yu et al., 2013) . The authors suggest that fractalkine might oppose glioma growth by promoting differentiation of Olig2-positive tumor initiating cells further down the oligodendrocyte lineage. Those of us who battle these tumors at the bench and at the bedside would look forward with great interest to a test of this hypothesis.
The generation of neurons and glia from radial glia progenitors is critical to proper neocortical development but the mechanisms regulating their deterministic production are unclear. In this issue of Neuron, Beattie et al. (2017) use elegant MADM-based lineage tracing to demonstrate cell-intrinsic and global functions for Lgl1 during neocortical development.
Radial glia progenitors (RGPs) are the principal neural precursor type in the developing neocortex, residing in the continuum of neural stem cell types between early neuroepithelial cells and postnatal neural stem cells . As such, RGPs are responsible for generating the diversity of neural types in the forebrain, including neurons, glia, ependymal cells, and persistent neural progenitor populations. Previous work has shown a deterministic pattern of cellular output from individual RGPs in terms of neuron generation ($8-9 per RGP) and gliogenic potential (1 in 6 RGP eventually generating glia) (Gao et al., 2014) . Though this seminal work provided insight into the intrinsic potential of individual RGPs, the mechanisms leading to the robust generation of appropriate daughter cell types remain incompletely understood.
The study by Beattie et al. (2017) describes the sequential roles for Lgl1 in embryonic and postnatal cortical histogenesis using MADM (mosaic analysis with double markers)-based mouse models to create sporadic and global RGP Lgl1 knockouts. Lgl1 is the homolog of Drosophila lethal giant larvae (aka l(2)gl)-the first neoplastic tumor suppressor gene described in the fly (Bridges and Brehme, 1944) . In Drosophila, Lgl1 mutants exhibit neoplastic overproliferation in the larval brain. The initial characterization of Lgl1 knockout in mice observed loss of apical junctions in the developing brain, formation of rosette structures, and overproliferation of progenitors that was balanced by apoptosis (Klezovitch et al., 2004) . However, the further study of Lgl1 function in vivo had been limited by the neonatal lethality of these Lgl1 global knockout mice. The need for more rigorous tools and indepth reexamination of phenotypes is a recurrent theme in neurodevelopment. Specifically, as the molecular underpinnings governing neocortical development are increasingly elucidated by the generation of mutation-induced phenotypes, increasing complexity arises in trying to pull apart the cell-and non-cellautonomous recycling of gene function in various cell types and stages of development. For example, Notch signalinganother key regulator of RGP fatehas been shown to exhibit pleiotropic functions at virtually every stage of neurodevelopment and brain maturation (Ables et al., 2011) . By employing the MADM methodology to examine the consequences of Lgl1 at single-cell resolution, Hippenmeyer and colleagues (Beattie et al., 2017) describe a diversity of cellular phenotypes at different stages of development.
MADM is a tool for somatic mutation that relies upon trans-recombination of MADM cassettes to produce in-frame coding sequences for fluorescent reporters (EGFP and TdTomato) during G2 phase of mitosis ( Figure 1A ). This elegant method of simultaneous genetic ablation and labeling has yielded significant insights into a number of critical scientific questions such as the aforementioned work demonstrating the deterministic production of neurons and glia (Gao et al., 2014) . In this study, chromosome 11 MADM cassettes were employed to work in tandem with an engineered Lgl1 conditional locus on the same chromosome. This allows for genetic manipulations of Lgl1 to be quantitatively and qualitatively elucidated at the single-cell level when combined with Cre recombinase expression. Two general approaches were employed. First, since Lgl1 À/À mice are lethal (Klezovitch et al., 2004) , Beattie et al. (2017) created either mosaic Lgl1 knockout (Lgl1-MADM) or tissue-wide conditional knockouts (cKO-Lgl1-MADM) in which Lgl1 can be deleted by Cre recombinase (driven by Emx1-Cre) in RGPs of the dorsal (cortical) ventricular zone ( Figure 1B Beattie et al. (2017) observed that Lgl1 regulates neuron and astrocyte specification at sequential stages of pre-and postnatal development. Specifically, at the embryonic stage, loss of Lgl1 in RGPs results in the overproduction of cortical neurons and the formation of a ''double'' cortex (subcortical band heterotopia), in the cKO-Lgl1-MADM animals. This was accompanied by the disruption of the ventricular zone (VZ) and mislocalization of apical and basolateral components in RGPs. In contrast, when Lgl1 is perturbed in a sparse population of cells, RGP proliferation is not impaired-suggesting that surrounding wild-type RGPs may be rescuing the mutant phenotype in a non-cell-autonomous manner. These findings speak to the Lgl1 À/À phenotype (seen in cKO-Lgl1-MADM) possibly resulting from impaired cell adhesion in the ''community'' of mutant cells. In regards to these findings, Beattie et al. (2017) note that the cellular phenotype of Lgl1
mice is similar to Numb/Numbl double mutants, in which it was found that the proteins regulated adhesion through trafficking of cadherins (Rasin et al., 2007) . Previous work of the co-authors report that Lgl1 À/À neural progenitors hyperproliferate, fail to exit the cell cycle, and are unable to localize Numb (Klezovitch et al., 2004 ). This suggests a role for Lgl1 in adherens junction formation and/ or maintenance, akin to that described for the Numb/Numbl endocytic adaptor proteins. A reduction in postnatal olfactory bulb neurogenesis was also observed in these animals, which Beattie et al. (2017) postulate may be due to dysgenesis of ependymal cells but also due to a cell-autonomous clustering of type B1 neural stem cells. Interestingly, compared with the highly penetrant, neoplastic, malignant nature of Drosophila l(2)gl mutants, no tumors were observed in this study. Further, it should be noted that far less than 1% of human brain tumors have shown any coding mutations in Lgl1 (COSMIC, http:// cancer.sanger.ac.uk/cosmic). Thus, a putative function as a critical tumor suppressor or driver gene in the mammalian brain remains uncorroborated, but its role in adhesion is increasingly substantiated.
Neonatally, RGPs are responsible for producing glial progenitors and neuroblasts destined for the olfactory bulb. While the molecular mechanisms-such as MEK-that orchestrate this gliogenesis are increasingly elucidated (Li et al., 2012) , precious little is known about the genetic factors that regulate the quantity of astrocytes generated from RGPs. In this respect, Beattie et al. (2017) report a drastic cell-autonomous increase in astrocyte proliferation when Lgl1 is mutated sparsely (Lgl1-MADM) or widely (cKO-Lgl1-MADM x Emx-Cre). After qualitatively analyzing the astrocytes generated, the authors find that Lgl1 manipulation does not impact the phenotype of the astrocytes, only their number. More specifically, Beattie et al. (2017) show that the increase in astrogliogenesis is a result of amplified intermediate astrocyte progenitor cell proliferation. Interestingly, this does not seem to occur at the expense of RGP depletion as is the case when genes such as Nf1 or Ras-which are upstream of MEK-are perturbed (Breunig et al., 2015) . Rather, the authors suggest that the increased astrogliogenesis may be a result of astrocyte progenitors not properly receiving/processing the extracellular cues necessary to regulate division or cell competition.
To interrogate a functional relationship with Lgl1 and astrogliogenesis, Beattie et al. (2017) investigated whether the increased astrogliogenesis in the Lgl1 À/À animals was dependent on Egfr. As Egfr is also on chromosome 11, double mutant Egfr/Lgl1 MADM cells were generated. Subsequent analysis revealed that the cell-autonomous Lgl1 phenotype of increased astrogliogenesis is dependent on Egfr. This finding further exhibits the potential of MADM for assessing dosage dependency and cell competition (due to the sparse labeling and distinct genetic reporters). Notably, this study begins to tease apart the differential regulation of type B1 neural stem cells at the ventricular surface when compared with parenchymal astrocyte progenitors. These cell types share many commonalities but display markedly different behaviors upon Lgl1 mutation ( Figure 1C) . This study and the MADM toolset utilized by Beattie et al. (2017) provides a framework that can be used to study stem cell specification and cell-/noncell-autonomous gene function in various organ systems. MADM provides unprecedented single-cell resolution of mutant cells and can be employed to virtually any candidate gene provided floxed alleles are available and the MADM cassettes are inserted on the same chromosome. In order to further study the mechanism(s) related to Lgl1 as well as other genes using MADM in development, subsequent studies will need to determine whether MADM cells can be successfully isolated (given their sparse number) for downstream analysis by single-cell RNA sequencing and proteomics. Also, while the MADM toolset is continually modified to increase robustness and flexibility, the field continues to develop complementary technologies with higher throughput such as in vivo CRISPR/Cas9 gene editing with viral transduction or electroporation-mediated transgenesis. With these combined techniques, increasingly complicated questions in brain neural stem cell biology can be unraveled. Indeed, much work remains to form an integrated understanding of the precise mechanisms regulating the deterministic behavior of RGPs and daughter lineages, but the work from Hippenmeyer and colleagues provides a solid foundation on which to build.
The development of the retina into a highly organized and conserved structure, composed of six types of neurons as well as Mueller glia, is a process tightly regulated in time and space. These different cell types are born in a stereotypical order, evolutionarily conserved across species. To achieve such diversity, lineage analyses have shown that there are multipotent proliferative cells, termed retinal progenitor cells or RPCs, which change over time. These analyses have also shown that some of these RPCs are specified to make only a single type of neuron, or a specific pair of very different types of neurons, in terminal divisions (Cepko, 2014) . In addition to lineage studies, much attention has been focused on the roles of transcription factors in the determination of the fate of retinal cell types, and in cataloguing gene expression, using all manner of RNA profiling methods, including singlecell RNA-seq. These previous studies have set the stage for analyses of the role of chromatin in regulating gene expression in retinal development and disease.
To decipher developmental gene regulatory programs, extensive efforts have been made to map cis-regulatory elements, particularly enhancers, that control spatio-temporal gene expression. Advances in genome-wide methods that map DNA and histone modifications, transcription factor binding, chromatin accessibility, and genome organization, along with advances in computational methods, have allowed an appreciation of the features that characterize hundreds of thousands of enhancers. The dynamic nuclear organization of the genome has an important role in transcription regulation during development, with topologically associated domains (TADs) emerging as fundamental structural units confining interactions between dispersed enhancers and their target genes (Dixon et al., 2015; Spitz 2016) . Since the chromatin landscape in which transcription factors operate is crucial to their ability to perform their regulatory roles, epigenetic modifications acquired during differentiation can lead to restrictions in the ability of transcription factors to affect cell fate, or other events. Aldiri et al. (2017) comprehensively characterized the dynamics of epigenome and transcriptome across multiple stages of normal retinal development in the mouse and in the human (Figure 1 ). DNA methylation was previously shown to be inversely correlated with transcriptional activity in the brain (Mo et al., 2015) , and Aldiri et al. (2017) profiled and analyzed these changes with respect to RNA levels in the retina. While changes in DNA methylation significantly accompanied changes in expression during murine development, further analyses on validated retinal gene sets showed that only a small subset (3%-38%) of those developmentally regulated genes had an inverse correlation. As expected, genes associated with retinal differentiation were upregulated during development, while progenitor and cell-cycle genes were silenced, and DNA methylation was more often associated with the former. To characterize other epigenetic changes,
